Royal DSM repurchased 346.038 of its own shares between 15 and 21 November 2013 at average price of €59.06

Heerlen, Netherlands, 22-11-2013 — /EuropaWire/ — Royal DSM, the global Life Sciences and Materials Sciences company, has repurchased 346.038 of its own shares in the period from 15 November 2013 up to and including 21 November 2013 at an average price of €59.06. This is in accordance with the repurchase, covering existing option plans, announced on 6 November 2013. The consideration of this repurchase was €20.4 million.

The total number of shares repurchased under this program to date is 563.765 shares for a total consideration of €33.1 million.

DSM – Bright Science. Brighter Living.™
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 23,500 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

For more information:
DSM Corporate Communications
Herman Betten
tel. +31 (0) 45 5782017
e-mail media.relations@dsm.com

DSM Investor Relations
Dave Huizing
tel. +31 (0) 45 5782864
e-mail investor.relations@dsm.com

Forward-looking statements
This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.